The FDA is to review Sanofi/Regeneron's Dupixent as a treatment ... the latest in a new wave of injected therapies, along with GlaxoSmithKline’s Nucala and Teva’s Cinqaero.
(Reuters) -GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday. The move comes as a multi-state ...
Sept 27 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a chronic ...